[Federal Register Volume 70, Number 241 (Friday, December 16, 2005)]
[Notices]
[Pages 74823-74827]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-24100]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[FDA 225-05-8000]


Memorandum of Understanding Between the United States Food and 
Drug Administration and the C-Path Institute

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is providing notice of 
a memorandum of understanding (MOU) between the United States Food and 
Drug Administration and the C-Path Institute. The specific purpose of 
this MOU is to establish an overarching framework for collaboration 
between the parties. This framework will be based on mutually agreed 
upon programs and activities in the areas of applied scientific 
research and training/education to foster the development of new 
evaluation tools to inform medical product development. The parties 
shall each leverage its own expertise and resources to facilitate 
programs of shared interests across the diverse disciplines of 
therapeutics, biological sciences, engineering and medical devices in 
building applied research and training/education programs. The 
appropriate formal agreements will be executed as required by law for 
any activities that result from this collaboration.

DATES: The agreement became effective October 14, 2005.

FOR FURTHER INFORMATION CONTACT: For C-Path Institute: Raymond L. 
Woosley, The Critical Path Institute, 4280 N. Campbell Ave., 
214, Tucson, AZ 85718, 520-547-3440, FAX: 520-547-3456, e-
mail: path.org">rwoosley@c-path.org.
    For The Food and Drug Administration: Mary I. Poos, Office of 
External Relations, Food and Drug Administration (HF-10), 5600 Fishers 
Lane, Rockville, MD 20857, 301-827-2825, FAX: 301-827-3042, e-mail: 
[email protected].

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 20.108(c), which 
states that all written agreements and MOUs between FDA and others 
shall be published in the Federal Register, the agency is publishing 
notice of this MOU.

    Dated: December 7, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
BILLING CODE 4160-01-S

[[Page 74824]]

[GRAPHIC] [TIFF OMITTED] TN16DE05.004


[[Page 74825]]


[GRAPHIC] [TIFF OMITTED] TN16DE05.005


[[Page 74826]]


[GRAPHIC] [TIFF OMITTED] TN16DE05.006

[GRAPHIC] [TIFF OMITTED] TN16DE05.007


[[Page 74827]]


[FR Doc. 05-24100 Filed 12-15-05; 8:45 am]
BILLING CODE 4160-01-C